Catalyst Event
Pfizer Inc (PFE) · Earnings Release
From Akros SCHK HK-US Biotech Index (ASHUBIO)
5/5/2026, 12:00:00 AM
High importance is estimated due to the potential for significant price volatility for Pfizer's Q1 2026 earnings release and conference call, scheduled.
Korean Translation
주가 영향 가능성을 고려하여 중요도를 '높음'으로 예상한 화이자 2026년 1분기 실적 발표 및 컨퍼런스 콜이 예정됨.
Related Recent Events
CSPC Pharmaceutical Group Ltd (1093) · Other
Final dividend of HKD 0.15 per share for FY2025 (total HKD 0.29, +11.5% YoY) with ex-dividend date June 24, 2026; low importance as dividend increases typically result in minor positive price adjustments scheduled.
6/24/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Earnings Release
Q1 2026 earnings release and conference call scheduled; typically results in moderate price movement.
4/30/2026, 12:00:00 AM
Bristol-Myers Squibb Co (BMY) · Earnings Release
Q1 2026 earnings release and conference call scheduled.
4/30/2026, 12:00:00 AM
Merck and Co Inc (MRK) · Earnings Release
Q1 2026 earnings release and conference call for 2026-04-30, estimated to have a low impact of ~1-2% based on historical trends, scheduled.
4/30/2026, 12:00:00 AM
Regeneron Pharmaceuticals Inc (REGN) · Earnings Release
Regeneron is scheduled to report its first quarter 2026 financial and operating results on 2026-04-29. Importance is Medium as earnings typically drive significant price movement, scheduled.
4/29/2026, 12:00:00 AM
Abbott Laboratories (ABT) · Earnings Release
Abbott Laboratories is scheduled to announce its first-quarter 2026 financial results before the market opens on April 16, 2026, scheduled.
4/16/2026, 12:00:00 AM